Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Intangibles (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Intangibles came in at $48.2 billion in Q2 2026, down 3.22% year-over-year from $49.8 billion in Q2 2025, and down 1.7% quarter-over-quarter from $49.1 billion in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Intangibles (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Intangibles across 18 years of filings, most recently posting $48.2 billion for Q2 2026.

  • In Q2 2026, Intangibles fell 3.22% year-over-year to $48.2 billion; the TTM figure through Jun 2026 stood at $48.2 billion (down 3.22% YoY), while the FY2025 annual figure was $50.4 billion, up 33.99% from the prior year.
  • Intangibles came in at $48.2 billion for Q2 2026 at Johnson & Johnson, down from $49.1 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $50.4 billion in Q4 2025 to a low of $34.2 billion in Q4 2023.
  • Average Intangibles over 5 years is $42.6 billion, with a median of $42.4 billion recorded in 2022.
  • Year-over-year, Intangibles slipped 27.74% in 2024 and jumped 33.99% in 2025.
  • Over 5 years, Intangibles stood at $40.3 billion in 2022, then dropped by 15.27% to $34.2 billion in 2023, then rose by 10.07% to $37.6 billion in 2024, then jumped by 33.99% to $50.4 billion in 2025, then retreated by 4.31% to $48.2 billion in 2026.
  • Per Business Quant data, the three most recent Intangibles figures were $48.2 billion in Q2 2026, $49.1 billion in Q1 2026, and $50.4 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 48.23 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 49.14 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn 42.07 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 47.05 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 17.39 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 30.64 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - 63.28 Mn
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn 60.96 Mn
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn 103.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 48.23 Bn
Mar 29, 2026 49.06 Bn
Dec 28, 2025 50.40 Bn
Sep 28, 2025 48.74 Bn
Jun 29, 2025 49.84 Bn
Mar 30, 2025 36.76 Bn
Dec 29, 2024 37.62 Bn
Sep 29, 2024 39.49 Bn
Jun 30, 2024 39.73 Bn
Mar 31, 2024 34.29 Bn
Dec 31, 2023 34.18 Bn
Oct 1, 2023 35.02 Bn
Jul 2, 2023 46.25 Bn
Apr 2, 2023 47.45 Bn
Jan 1, 2023 38.49 Bn
Oct 2, 2022 40.34 Bn
Jul 3, 2022 42.41 Bn
Apr 3, 2022 44.42 Bn
Jan 2, 2022 46.39 Bn
Oct 3, 2021 47.78 Bn